Press Release Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity Aug 11
Press Release Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH Jul 23